loadpatents
name:-0.018167018890381
name:-0.0066900253295898
name:-0.0029771327972412
LIN; Al Y. Patent Filings

LIN; Al Y.

Patent Applications and Registrations

Patent applications and USPTO patent grants for LIN; Al Y..The latest application filed is for "methods for treating anemia in subjects having kidney failure using inhibitors of hypoxia-inducible factor (hif) hydroxylase".

Company Profile
3.6.23
  • LIN; Al Y. - Castro Valley CA
  • Lin; Al Y. - San Francisco CA
  • Lin; Al Y - Castro Valley CA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Methods For Treating Anemia In Subjects Having Kidney Failure Using Inhibitors Of Hypoxia-inducible Factor (hif) Hydroxylase
App 20210369702 - KLAUS; Stephen J. ;   et al.
2021-12-02
Connective Tissue Growth Factor Antibodies
App 20210230259 - LIN; Al Y. ;   et al.
2021-07-29
Enhanced Erythropoiesis And Iron Metabolism
App 20210107878 - Klaus; Stephen J. ;   et al.
2021-04-15
Enhanced erythropoiesis and iron metabolism
Grant 10,927,081 - Klaus , et al. February 23, 2
2021-02-23
Connective Tissue Growth Factor Antibodies
App 20190023778 - LIN; Al Y. ;   et al.
2019-01-24
Methods For Treating A Neurological Disorder In A Subject Using Inhibitors Of Hypoxia-inducible Factor (hif) Proyl Hydroxylase
App 20170312268 - KLAUS; Stephen J. ;   et al.
2017-11-02
Connective Tissue Growth Factor Antibodies
App 20160257740 - Lin; Al Y. ;   et al.
2016-09-08
Connective Tissue Growth Factor Antibodies
App 20160024198 - LIN; AL Y. ;   et al.
2016-01-28
Connective tissue growth factor antibodies
Grant 9,034,643 - Lin , et al. May 19, 2
2015-05-19
Methods For Treating Anemia In Subjects Having Kidney Failure Using Inhibitors Of Hypoxia-inducible Factor (hif) Hydroxylase
App 20150080425 - KLAUS; STEPHEN J. ;   et al.
2015-03-19
Treatment For High Cholesterol
App 20150018384 - Lin; Al Y ;   et al.
2015-01-15
Connective Tissue Growth Factor Antibodies
App 20140073047 - Lin; Al Y. ;   et al.
2014-03-13
Methods for treating anemia using inhibitors of hypoxia-inducible factor (HIF) hydroxylase
App 20130203805 - Klaus; Stephen J. ;   et al.
2013-08-08
Fat regulation
Grant 8,202,834 - Fourney , et al. June 19, 2
2012-06-19
Methods for treating anemia using inhibitors of hypoxia-inducible factor (HIF) hydroxylase
App 20110166178 - Klaus; Stephen J. ;   et al.
2011-07-07
Connective tissue growth factor antibodies
App 20110091468 - Lin; Al Y. ;   et al.
2011-04-21
Antibodies that bind to a portion of the VWC domain of connective tissue growth factor
Grant 7,871,617 - Lin , et al. January 18, 2
2011-01-18
Fat regulation
App 20100168152 - Fourney; Patrick D. ;   et al.
2010-07-01
Fat regulation
Grant 7,618,940 - Fourney , et al. November 17, 2
2009-11-17
Connective tissues growth factor antibodies
App 20090017043 - Lin; Al Y. ;   et al.
2009-01-15
Connective tissue growth factor antibodies
Grant 7,405,274 - Lin , et al. July 29, 2
2008-07-29
Methods of increasing endogenous erythropoietin (EPO)
App 20060183695 - Klaus; Stephen J. ;   et al.
2006-08-17
Methods of increasing endogenous erythropoietin (EPO)
App 20060178316 - Klaus; Stephen J. ;   et al.
2006-08-10
Methods of increasing endogenous erythropoietin (EPO)
App 20060178317 - Klaus; Stephen J. ;   et al.
2006-08-10
Connective tissue growth factor antibodies
App 20040248206 - Lin, Al Y. ;   et al.
2004-12-09
Fat regulation
App 20040235082 - Fourney, Patrick D. ;   et al.
2004-11-25
Methods of increasing endogenous erythropoietin (EPO)
App 20030153503 - Klaus, Stephen J. ;   et al.
2003-08-14

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed